| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |